Monoclonal gammopathy of clinical importance
Monoclonal gammopathy is a frequent finding and may be associated with severe cancer such as myelomatosis and other B-cell lymphoproliferative disorders. However, the monoclonal component can also be the direct cause of serious disease, namely monoclonal gammopathy of clinical significance (MGCS). MGCS is most likely significantly underdiagnosed and is consequently also undertreated. In order to achieve a good therapeutic outcome, it is crucial that the condition is recognised at an early stage, so that treatment can be initiated before the patient has developed irreversible organ damage. Increased awareness of MCGS is therefore essential.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:141 |
|---|---|
| Enthalten in: |
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke - 141(2021), 2021-13 vom: 28. Sept. |
| Sprache: |
Norwegisch |
|---|
| Weiterer Titel: |
Monoklonal gammopati av klinisk betydning |
|---|
| Beteiligte Personen: |
Tjønnfjord, Geir E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.10.2021 Date Revised 19.11.2021 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.4045/tidsskr.20.0981 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33138406X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33138406X | ||
| 003 | DE-627 | ||
| 005 | 20231225213336.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||nor c | ||
| 024 | 7 | |a 10.4045/tidsskr.20.0981 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1104.xml |
| 035 | |a (DE-627)NLM33138406X | ||
| 035 | |a (NLM)34596996 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a nor | ||
| 100 | 1 | |a Tjønnfjord, Geir E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Monoclonal gammopathy of clinical importance |
| 246 | 3 | 3 | |a Monoklonal gammopati av klinisk betydning |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.10.2021 | ||
| 500 | |a Date Revised 19.11.2021 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Monoclonal gammopathy is a frequent finding and may be associated with severe cancer such as myelomatosis and other B-cell lymphoproliferative disorders. However, the monoclonal component can also be the direct cause of serious disease, namely monoclonal gammopathy of clinical significance (MGCS). MGCS is most likely significantly underdiagnosed and is consequently also undertreated. In order to achieve a good therapeutic outcome, it is crucial that the condition is recognised at an early stage, so that treatment can be initiated before the patient has developed irreversible organ damage. Increased awareness of MCGS is therefore essential | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Schjesvold, Fredrik H |e verfasserin |4 aut | |
| 700 | 1 | |a Gulbrandsen, Nina |e verfasserin |4 aut | |
| 700 | 1 | |a Kvam, Ann Kristin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke |d 1946 |g 141(2021), 2021-13 vom: 28. Sept. |w (DE-627)NLM00004475X |x 0807-7096 |7 nnns |
| 773 | 1 | 8 | |g volume:141 |g year:2021 |g number:2021-13 |g day:28 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4045/tidsskr.20.0981 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 141 |j 2021 |e 2021-13 |b 28 |c 09 | ||